Pharma Deals Review, Vol 2009, No 6 (2009)

Font Size:  Small  Medium  Large

Agreement Between Roche and Tekmira to Advance RNAi Product Candidates

Taskin Ahmed

Abstract


Tekmira Pharmaceuticals and Roche announced a product development agreement to advance Roche’s first two RNAi product candidates into human clinical testing. Both RNAi product candidates are to be based on Tekmira’s SNALP technology.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.